(6-(4-Methyl-1H-pyrazol-1-yl)pyridin-2-yl)boronic acid, 95+%, 1g

3-CHLORO-5-[1-[(4-METHYL-5-OXO-1H-1,2,4-TRIAZOL-3-YL)METHYL]-2-OXO-4-(TRIFLUOROMETHYL)PYRIDIN-3-YL]OXYBENZONITRILE, 98%, 5mg

Azelaic acid, min. 80%, 25 g, plastic packaging.

3-NITROPYRIDINE-2-CARBOXAMIDE, 95.0%, 250mg

(S)-3-Isopropylmorpholine, 95.0%, 5g

Potassium trifluoro((4-methylpiperazin-1-yl)methyl)borate, 95.0%, 25g

6-(Trifluoromethyl)benzo[d]thiazole-2(3H)-thione, 97%, 1g

4-Formylfuran-2-carboxylic acid, 98%, 50mg

2,2',2''-(1,4,7-Triazonane-1,4,7-triyl)triacetic Acid, >98.0%(HPLC), 50mg

Hafnium oxide dichloride hydrate 98+% 100 g

4-p-Tolyl-thiazol-2-ylamine, 95.0%, 10g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-acetamidopentanoic acid, 98%, 100mg

7-Methyl-2-((7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino)-9-(tetrahydro-2H-pyran-4-yl)-7H-purin-8(9H)-one, 98.0%, 10mg